Prof Christopher (Chris) Nolan is a clinician/scientist/teacher/policy advisor in diabetes. He completed his training in Medicine at the University of Melbourne (BMedSc and MBBS-1983) and Endocrinology at The Royal Melbourne Hospital (FRACP-1991). He received his doctoral degree from the University of Melbourne on glucose metabolism and insulin action in pregnancy under the supervision of Prof Joe Proietto (1998). He received further training in islet beta-cell research at the University of Montreal under supervision of Prof Marc Prentki (2002-4). He moved to Canberra to join the Endocrinology Department at The Canberra Hospital and the ANU Medical School in 2005. He is currently Associate Dean of Research and Professor of Endocrinology for the ANU Medical School, Chair of the ANU College of Health and Medicine Research Committee, and a Senior Staff Specialist in Endocrinology at Canberra Health Services. In 2018 he stepped down as Director of Diabetes Services (2011-2018) and Director of Endocrinology (2016-2018) at the Canberra Hospital. Under his leadership, the ACT Health Diabetes Service was recognised as a National Centre of Excellence by the National Association of Diabetes Centres. Prof Nolan is currently a Board Member of the Australian Diabetes Society and Co-Chair of the Advisory Committee of the Diabetes Australia Research Program. He has previously been President of the Australasian Diabetes in Pregnancy Society and Council Member of the International Association of Diabetes in Pregnancy Study Groups. He is an Advisory Board Member for Diabetologia (2020-) and an International Review Panel Member for the Danish Diabetes Academy Committee for Talent Development (2018-). He directs an active diabetes research laboratory at the John Curtin School of Medical Research focusing on islet beta-cell failure in type 1 and 2 diabetes and the role of insulin hypersecretion in metabolic syndrome and related conditions. He is involved in multicentre diabetes clinical studies including the NHMRC funded Treatment of Booking Gestational Diabetes (TOBOGM) study. He is a lead investigator for the ANU Grand Challenge project, Our Health in Our Hands, which includes research into improving the care of people with type 1 diabetes using a personalised medicine approach.

​